Akeem Lewis, M.D.

I am deeply committed to patient-centered care with a strong focus on education and open communication through a foundation of evidence-based medicine.

I believe when you are well-informed about your condition and treatment options, you can make the best decisions for your unique situation. By fostering a supportive environment and providing personalized information, I will strive to empower you and help you feel in control of your journey.

Education

• St. George's University School of Medicine 

Residencies

• Internal Medicine, State University of New York Downstate Medical Center
• Internal Medicine, Memorial Sloan-Kettering Cancer Center

Fellowship

• Hematology/Oncology, Mayo Clinic School of Graduate Medical Education

Certification

• Internal Medicine, American Board of Internal Medicine

Memberships

• Alpha Omega Alpha Honor Medical Society
• American Society of Clinical Oncology
• American Society of Clinical Oncology Trainee and Early Career Advisory Group
• American Society of Hematology

Academic Appointments

• Instructor in Medicine, Mayo Clinic College of Medicine and Science
• Instructor in Oncology Mayo Clinic College of Medicine and Science

• Bladder cancer
• General oncology
• Global oncology
• Health care delivery
• Hematology
• Immunotherapy
• Kidney cancer
• Medical education
• Prostate cancer
• Targeted therapy
• Testicular cancer

• Role of individual factor X concentrate pharmacokinetic studies in perioperative management of AL amyloidosis-associated acquired factor X deficiency, July 2023.
• A review of theranostics: Perspectives on emerging approaches and clinical advancements, July 2023.
• Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer, May 2023.
• Outcomes of second-line therapies in patients with metastatic de Novo and treatment-emergent neuroendocrine prostate cancer: A multi-institutional study, April 2023.
• Acquired factor VIII deficiency in prostate adenocarcinoma presenting as multiple hematomas and hemarthrosis, February 2020.